Sfoglia per Autore  

Opzioni
Mostrati risultati da 41 a 60 di 86
Titolo Data di pubblicazione Autore(i) File
Stability and Degradation Pathways of Different Psychoactive Drugs in Neat and in Buffered Oral Fluid 1-gen-2020 Marchei, E.; Malaca, S.; Graziano, S.; Gottardi, M.; Pichini, S.; Busardo, F. P.
Toxicology and analysis of psychoactive tryptamines 1-gen-2020 Malaca, S.; Lo Faro, A. F.; Tamborra, A.; Pichini, S.; Busardo, F. P.; Huestis, M. A.
Δ9-Tetrahydrocannabinol and Cannabidiol Time Courses in the Sera of "Light Cannabis" Smokers: Discriminating Light Cannabis Use from Illegal and Medical Cannabis Use 1-gen-2020 Pichini, S.; Mannocchi, G.; Berretta, P.; Zaami, S.; Pirani, F.; Pacifici, R.; Busardo, F. P.
Monitoring Prenatal Exposure to Buprenorphine and Methadone 1-gen-2020 Di Trana, A.; La Maida, N.; Tittarelli, R.; Huestis, M. A.; Pichini, S.; Busardo, F. P.; Carlier, J.
Measurement uncertainty in forensic toxicology 1-gen-2020 Malaca, S.; Carlier, J.; Pichini, S.; Busardo, F. P.
Commentary - Heroin purity and adulteration: An updated snapshot from the Italian Early Warning System 1-gen-2020 Tittarelli, R.; Di Luca, N. M.; Pacifici, R.; Pichini, S.; Del Rio, A.; Busardo, F. P.
Nails analysis for drugs used in the context of chemsex: A pilot study 1-gen-2020 Busardo, F. P.; Gottardi, M.; Pacifici, R.; Vari, M. R.; Tini, A.; Volpe, A. R.; Giorgetti, R.; Pichini, S.
Testing Unconventional Matrices to Monitor for Prenatal Exposure to Heroin, Cocaine, Amphetamines, Synthetic Cathinones, and Synthetic Opioids 1-gen-2020 Carlier, J.; La Maida, N.; Di Trana, A.; Huestis, M. A.; Pichini, S.; Busardo, F. P.
Fast and sensitive UHPLC-MS/MS analysis of cannabinoids and their acid precursors in pharmaceutical preparations of medical cannabis and their metabolites in conventional and non-conventional biological matrices of treated individual 1-gen-2020 Pichini, S.; Mannocchi, G.; Gottardi, M.; Perez-Acevedo, A. P.; Poyatos, L.; Papaseit, E.; Perez-Mana, C.; Farre, M.; Pacifici, R.; Busardo, F. P.
Disposition of cannabidiol metabolites in serum and urine from healthy individuals treated with pharmaceutical preparations of medical cannabis 1-gen-2020 Perez-Acevedo, A. P.; Busardo, F. P.; Pacifici, R.; Mannocchi, G.; Gottardi, M.; Poyatos, L.; Papaseit, E.; Perez-Mana, C.; Martin, S.; Di Trana, A.; Pichini, S.; Farre, M.
Determination of the synthetic cannabinoids JWH-122, JWH-210, UR-144 in oral fluid of consumers by GC-MS and quantification of parent compounds and metabolites by UHPLC-MS/MS 1-gen-2020 Maida, N. L.; Pellegrini, M.; Papaseit, E.; Perez-Mana, C.; Poyatos, L.; Ventura, M.; Galindo, L.; Busardo, F. P.; Pichini, S.; Farre, M.; Marchei, E.
Herbal preparations of medical cannabis: A vademecum for prescribing doctors 1-gen-2020 Brunetti, P.; Pichini, S.; Pacifici, R.; Busardo, F. P.; del Rio, A.
Pharmacology and legal status of cannabidiol 1-gen-2020 Brunetti, P.; Lo Faro, A. F.; Pirani, F.; Berretta, P.; Pacifici, R.; Pichini, S.; Busardo, F. P.
Monitoring Perinatal Exposure to Cannabis and Synthetic Cannabinoids 1-gen-2020 Carlier, J.; Huestis, M. A.; Zaami, S.; Pichini, S.; Busardo, F. P.
Medicinal cannabis and synthetic cannabinoid use 1-gen-2020 Pichini, S.; LO FARO, Alfredo Fabrizio Francesco; Busardo, F. P.; Giorgetti, R.
The National Early Warning System, a web-based platform to prevent the spread of New Psychoactive Substances 1-gen-2021 Vari, M. R.; Zaami, S.; Pacifici, R.; Pichini, S.; Berretta, P.; Sciotti, M.; Tittarelli, R.; La Maida, N.; Tini, A.; Marinelli, E.; Buscaglia, E.; Brambilla, E.; Scaravaggi, G.; Locatelli, C. A.; Busardo, F. P.; Cavallo, M.; Graziano, S.
UHPLC-MS/MS analysis of cannabidiol and its metabolites in serum of patients with resistant epilepsy treated with CBD formulations 1-gen-2021 Malaca, S.; Gottardi, M.; Pigliasco, F.; Barco, S.; Cafaro, A.; Amadori, E.; Riva, A.; Marcenaro, M.; Striano, P.; Cangemi, G.; Pacifici, R.; Pichini, S.; Busardo, F. P.
Disposition of phytocannabinoids, their acidic precursors and their metabolites in biological matrices of healthy individuals treated with vaporized medical cannabis 1-gen-2021 Busardo, F. P.; Perez-Acevedo, A. P.; Pacifici, R.; Mannocchi, G.; Gottardi, M.; Papaseit, E.; Perez-Mana, C.; Martin, S.; Poyatos, L.; Pichini, S.; Farre, M.
The complex and constantly evolving public health threat of new psychoactive substances in Italy: Addressing the main functions of a national observatory of drugs 1-gen-2021 Graziano, S.; Zaami, S.; Tittarelli, R.; Pichini, S.; Sciotti, M.; Berretta, P.; Busardo, F. P.; Marinelli, E.; Tini, A.; Scaravaggi, G.; Buscaglia, E.; Brambilla, E.; Cavallo, M.; Locatelli, C. A.; Pacifici, R.; Vari, M. R.
UHPLC-MS/MS analysis of cannabidiol metabolites in serum and urine samples. Application to an individual treated with medical cannabis 1-gen-2021 Pichini, S.; Malaca, S.; Gottardi, M.; Perez-Acevedo, A. P.; Papaseit, E.; Perez-Mana, C.; Farre, M.; Pacifici, R.; Tagliabracci, A.; Mannocchi, G.; Busardo, F. P.
Mostrati risultati da 41 a 60 di 86
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile